Fast determination of tobramycin by reversed-phase ion-pair high performance liquid chromatography with a refractive index detector

Liang ZHU , Jingkang WANG

Front. Chem. Sci. Eng. ›› 2013, Vol. 7 ›› Issue (3) : 322 -328.

PDF (155KB)
Front. Chem. Sci. Eng. ›› 2013, Vol. 7 ›› Issue (3) : 322 -328. DOI: 10.1007/s11705-013-1348-z
RESEARCH ARTICLE
RESEARCH ARTICLE

Fast determination of tobramycin by reversed-phase ion-pair high performance liquid chromatography with a refractive index detector

Author information +
History +
PDF (155KB)

Abstract

A simple and direct method without a derivation step for routine analysis of tobramycin has been developed. This method used reversed-phase ion-pair high performance liquid chromatography (HPLC) with a refractive index (RI) detector and a C18 column which is stable at pH above 1.00. The presence of 4.50 mg·mL-1 trifluoroacetic acid (TFA) in the mobile phase improved the protonation of tobramycin and the formation of ion-pairs, and thus reduced its hydrophility. This unique separation–detection combination showed good linearity with correlation coefficients 0.9996 in the concentration range of 0.25–2.50 mg·mL-1. The quantitation limit and detection limit were determined to be 0.23 mg·mL-1 and 0.071 mg·mL-1, respectively. Tobramycin was recovered in 98.00%, 98.84% and 99.64% for tobramycin solutions at concentrations of 2.25 mg·mL-1, 1.50 mg·mL-1 and 0.75 mg·mL-1, respectively. The relative standard deviations for six spiked samples ranged from 0.20% to 2.40%, indicating a good reproducibility of this method.

Keywords

tobramycin / aminoglycoside / refractive index detector / high-performance liquid chromatography / ion-pairing

Cite this article

Download citation ▾
Liang ZHU, Jingkang WANG. Fast determination of tobramycin by reversed-phase ion-pair high performance liquid chromatography with a refractive index detector. Front. Chem. Sci. Eng., 2013, 7(3): 322-328 DOI:10.1007/s11705-013-1348-z

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Higgins C E, Kastner R E. Nebramycin, a new broad-spectrum antibiotic complex. II. Description of Streptomyces tenebrarius. Antimicrob Agents Chemother (Bethesda), 1967, 7: 324–331

[2]

Siegenthaler W E, Bonetti A, Luthy R. Aminoglycoside antibiotics in infectious diseases. An overview. American Journal of Medicine, 1986, 80(6): 2–14

[3]

Lode H. Tobramycin: A review of therapeutic uses and dosing schedules. Current Therapeutic Research, 1998, 59(7): 420–453

[4]

Hussey R L. Paper chromatography of tobramycin and some related compounds. Journal of Chromatography. A, 1974, 92(2): 457–460

[5]

Kadar-Pauncz J. Separation of nebramycin components by thin-layer chromatography. Journal of Chromatography. A, 1979, 170(1): 203–207

[6]

Mayhew J W, Gorbach S L. Gas-liquid chromatographic method for the assay of aminoglycoside antibiotics in serum. Journal of Chromatography. A, 1978, 151(2): 133–146

[7]

James A R. Colorimetric determination of gentamicin, kanamycin, tobramycin, and amikacin aminoglycosides with 2,4-dinitrofluorobenzene. Journal of Pharmaceutical Sciences, 1984, 73(9): 1301–1302

[8]

Suchitra S S. Comparison of new and existing spectrophotometric methods for the analysis of tobramycin and other aminoglycosides. Journal of Pharmaceutical Sciences, 1990, 79(5): 428–431

[9]

Lai F, Sheehan T. Enhancement of detection sensitivity and cleanup selectivity for tobramycin through pre-column derivatization. Journal of Chromatography. A, 1992, 609(1-2): 173–179

[10]

Fabre H, Sekkat M, Blanchin M D, Mandrou B. Determination of aminoglycosides in pharmaceutical formulations. II. High-performance liquid chromatography. JournalβofβPharmaceuticalβand Biomedical Analysis, 1989, 7(7): 1711–1718

[11]

Essers L. An automated high-performance liquid chromatographic method for the determination of aminoglycosides in serum using pre-column sample clean-up and derivatization. Journal of Chromatography. B, Biomedical Sciences and Applications, 1984, 305(2): 345–352

[12]

James A R. Colorimetric determination of gentamicin, kanamycin, tobramycin, and amikacin aminoglycosides with 2,4-dinitrofluorobenzene. Journal of Pharmaceutical Sciences, 1984, 73(9): 1301–1302

[13]

Russ H, McCleary D, Katimy R, Montana J L, Miller R B, Krishnamoorthy R, Davis C W. Development and validation of a stability-indicating HPLC method for the determination of tobramycin and its related substances in an ophthalmic suspension. Journal of Liquid Chromatography & Related Technologies,, 1998, 21(4): 2165–2181

[14]

Barends D M, Zwaan C L, Hulshoff A. Micro-determination of tobramycin in serum by high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography. B, Biomedical Sciences and Applications, 1981, 225(2): 417–426

[15]

Barends D M, Brouwers J C, Hulshoff A. Fast pre-column derivatization of aminoglycosides with 1-fluoro-2,4-dinitrobenzene and its application to pharmaceutical analysis. Journal of Pharmaceutical and Biomedical Analysis, 1987, 5(6): 613–620

[16]

Gambardella P, Punziano R, Gionti M, Guadalupi C, Mancini G, Mangia A. Quantitative determination and separation of analogues of aminoglycoside antiobiotcs by high-performance liquid chromatography. Journal of Chromatography. A, 1985, 348(1): 229–240

[17]

Feng C H, Lin S J, Wu H L, Chen S H. Trace analysis of tobramycin in human plasma by derivatization and high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 2002, 780(2): 349–354

[18]

The United States Pharmacopeial Convention.The United States Pharmacopeia 29/the National Formulary 24, 2006

[19]

European Medicines Quality Authority. European Pharmacopoeiaβ. France Strasbourg: European Drug Quality of Medicines (EDQM), 2002

[20]

Szunyog J, Adams E, Roets E, Hoogmartens J. Analysis of tobramycin by liquid chromatography with pulsed electrochemical detection. JournalβofβPharmaceuticalβand Biomedical Analysis, 2000, 23(5): 891–896

[21]

Mohamed N E, Jos H, Erwin A, Ann V S. Optimization of capillary electrophoresis method with contactless conductivity detection for the analysis of tobramycin and its related substances. Journal of Pharmaceutical and Biomedical Analysis, 2012, 58: 49–57

[22]

Keevil B G, Lockhart S J, Cooper D P. Determination of tobramycin in serum using liquid chromatography-tandem mass spectrometry and comparison with a fluorescence polarisation assay. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 2003, 794(2): 329–335

[23]

Jezowska-Bojczuk M, Karaczyn A, Kozlowski H. Copper(II) binding to tobramycin: Potentiometric and spectroscopic studies. Carbohydrate Research, 1998, 313(3-4): 265–269

[24]

Soltes L. Aminoglycoside antibiotics—two decades of their HPLC bioanalysis. Biomedical Chromatography, 1999, 13(1): 3–10

[25]

Guo M X, Wrisley L, Maygoo E. Measurement of tobramycin by reversed-phase high-performance liquid chromatography with mass spectrometry detection. Analytica Chimica Acta, 2006, 571(1): 12–16

RIGHTS & PERMISSIONS

Higher Education Press and Springer-Verlag Berlin Heidelberg

AI Summary AI Mindmap
PDF (155KB)

3772

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/